Home/Filings/4/0000950170-24-126558
4//SEC Filing

Caplan Jay David 4

Accession 0000950170-24-126558

CIK 0001572616other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 6:25 PM ET

Size

9.9 KB

Accession

0000950170-24-126558

Insider Transaction Report

Form 4
Period: 2024-11-10
Caplan Jay David
President, Chief Product Off.
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2024-11-10187,2570 total
    Common Stock (187,257 underlying)
  • Exercise/Conversion

    Common Stock

    2024-11-10+187,257217,741 total
  • Sale

    Common Stock

    2024-11-11$2.47/sh64,197$158,541153,544 total
Holdings
  • Common Stock

    (indirect: By Trust)
    118,810
  • Common Stock

    (indirect: By Trust)
    358,806
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date.
  • [F2]Represents shares sold for tax-withholding purposes due upon the vesting of the restricted stock units.

Documents

1 file

Issuer

FRACTYL HEALTH, INC.

CIK 0001572616

Entity typeother

Related Parties

1
  • filerCIK 0001419217

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 6:25 PM ET
Size
9.9 KB